The Right Amount of Purge Useful for Blood Sampling on PiccLine (PiccLine)

Sponsor
Rennes University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05763186
Collaborator
(none)
60
1
2
12
5

Study Details

Study Description

Brief Summary

An increasing number of patients are receiving central lines, including PiccLine systems for the administration of therapeutics and nutrition.

Although these systems are not theoretically intended for blood collection, nurses prefer them as a puncture site when they are in place in their patients, saving them from further peripheral puncture in people who generally do not have optimal venous capital.

It is essential to purge the tubing in place in the patient and filled with infusion solution before drawing blood. Although the dead volume of the tubing used does not exceed 2mL, the volume of purging required before filling tubes for the laboratory appears to be much greater. Anecdotal evidence suggests a useful volume of 20ml but this has never been clearly demonstrated. In addition, the Biochemistry laboratory regularly sees blood samples diluted with perfusion solution, as evidenced by biochemical assays, leading to the cancellation of analyses received in the laboratory and a new sample being taken. This increases blood spoliation for these often already anaemic patients.

There is no consensus in the literature on recommendations for such sampling in PiccLine patients:

  • The CLSI1 (Clinical and Laboratory Standart Institute), a non-governmental organisation, issued sampling recommendations in 2017 that were taken up by Becton Dickinson2, a supplier of blood collection tubes. These recommendations include:

  • Rinse with 10 ml of 0.9% NaCl

  • Then a purge of 3 to 11 ml (depending on the analysis sought)

  • English-language articles3,4,5,6,7 show purge volumes ranging from 3 to 6 ml with significantly different sampling methods (rinsing or not).

The investigators therefore note a discrepancy between the sampling practices of the university hospital and the recommendations of the CLSI. In fact, the investigators noted a lack of rinsing prior to purging, which could explain the difference between 20 and 3 ml. This raises the issue of protocolisation of this type of sampling in order to standardise practices.

A consultation of other hospitals, carried out beforehand, enabled us to note that French practices are not in agreement with these recommendations. The management of the Rennes University Hospital as well as the Haute Autorité de Santé were contacted in order to confirm that no normative document had been published or was being drafted on this subject.

The fields of study are: sampling practices on PiccLine, the pre-analytical phase in medical biology.

Condition or Disease Intervention/Treatment Phase
  • Other: Sampling
  • Other: Sampling and rinsing
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
The Right Amount of Purge Useful for Blood Sampling on PiccLine
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2023
Anticipated Study Completion Date :
Apr 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Sampling

On the PiccLine: a collection of 6 consecutive heparinized tubes with 3.5ml gel corresponding to the usual purge volume In the periphery : one 3.5ml heparin-gel tube as a reference.

Other: Sampling
Comparison of the results of the biological examinations obtained on the 6 tubes collected on the PiccLine with the results of the biological examinations obtained on the peripheral sample.

Experimental: Sampling and rinsing

On the PiccLine: a 10 ml pre-rinsing with 0.9% NaCl and then a sampling of 6 consecutive heparinized tubes with 3.5ml gel corresponding to the usual purge volume. In the periphery: one 3.5 ml heparin-gel tube as a reference.

Other: Sampling and rinsing
Comparison of the results of the biological examinations obtained on the 6 tubes collected on the PiccLine with the results of the biological examinations obtained on the peripheral sample.

Outcome Measures

Primary Outcome Measures

  1. Lowest purge volume to obtain a biological result in the PiccLine sample that matches the peripheral sample taken from the same patient at the same time for the following assays: - Sodium, potassium and chlorine - Creatinine - Glucose [during 2 days follow-up]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age ≥ 18 years

  2. Carrier of PiccLine one way polyurethane

  3. Hospitalized in a clinical hematology unit This criterion minimises patient and practice heterogeneity.

  4. PiccLine placement not older than 48 hours

  5. Injection of at least one solution

  6. Affiliated to a social security scheme

  7. Having signed a free, informed and written consent

Exclusion Criteria:
  1. Anemia below the transfusion threshold (hemoglobin level < 7 g/dL) in relation to the patient's pathology

  2. Parenteral nutrition

  3. Peripheral venous sampling not possible (insufficient venous capital)

  4. Protected person (adult subject to legal protection (safeguard of justice, curatorship, guardianship), person deprived of liberty, pregnant woman (declarative), breastfeeding woman and minor).

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Rennes Rennes France

Sponsors and Collaborators

  • Rennes University Hospital

Investigators

  • Principal Investigator: Eric Geffray, CHU Rennes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rennes University Hospital
ClinicalTrials.gov Identifier:
NCT05763186
Other Study ID Numbers:
  • 35RC22_9907-2_PiccLine
  • 2022-A01383-40
First Posted:
Mar 10, 2023
Last Update Posted:
Mar 13, 2023
Last Verified:
Feb 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rennes University Hospital

Study Results

No Results Posted as of Mar 13, 2023